Latest News & Updates
Breaking News
13 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Morepen Begins Commercial Supplies Under Rs. 825 Crore CDMO Contract
Morepen Laboratories activates commercial supply under an Rs. 825 crore CDMO contract, marking a shift from agreement to GMP-compliant production.
Pharma Now Editorial Team
Mankind Pharma Signs AI Drug Discovery Deal with Denovo Sciences to Accelerate Lead Candidate Selection
Mankind Pharma partners with Denovo Sciences to embed AI into early drug discovery, targeting shorter timelines and stronger lead candidates.
Pharma Now Editorial Team
Telix Pharmaceuticals Gains FDA Alignment on ProstACT Global Phase 3 Trial Statistical Framework
Telix gains FDA alignment on ProstACT Global Phase 3 statistical framework, clearing the path for a U.S. IND amendment for TLX591-Tx in mCRPC.
Pharma Now Editorial Team
60 Degrees Pharmaceuticals Gains DSMB Clearance to Continue Tafenoquine Phase 2 Study in Chronic Babesiosis
60 Degrees Pharmaceuticals' DSMB clears B-FREE Phase 2 to continue, advancing tafenoquine into an indication with no existing FDA-approved treatment.
Pharma Now Editorial Team
